Regeneron and Bayer settle appeal over launch of Eylea biosimilar
MELBOURNE: Biotech Regeneron and drug company Bayer have resolved their appeal of a ruling that
MELBOURNE: Biotech Regeneron and drug company Bayer have resolved their appeal of a ruling that